Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 21, 2026Current Genomics

Genomics-Driven Immunotherapy: Advancing Cancer Treatment through Personalized Approaches

View Full Paper
Ask AI
Bookmark
Share

Authors

AKAditi KateSDSharav DesaiSSSiddhi P. Sapkal

Discussion

Loading...

Member takes

Overview

This review highlights genomics-driven strategies to enhance immunotherapy effectiveness in cancer, suggesting personalized treatments could improve outcomes.

Key Points

  • The central aim is to explore how genomics can personalize immunotherapy approaches for cancer treatment.
  • Review of genomic profiling techniques to identify molecular biomarkers.
  • Discussion on the role of the tumor microenvironment in treatment responses.
  • Analysis of innovative technologies like CRISPR and single-cell RNA sequencing.
  • Genomic profiling aids in predicting patient responses to immunotherapy.
  • Personalized strategies can potentially overcome challenges like tumor heterogeneity.
  • Emerging technologies show promise in refining treatment strategies for better outcomes.

Cite This Study

Kate et al. (2026) studied this question.

synapsesocial.com/papers/69e7143fcb99343efc98db0chttps://doi.org/10.2174/0113892029403241260416110923
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1The role of immunogenomics in advancing precision immunotherapy for non-small cell lung cancer2025 · 1 citations
  2. 2Transforming Cancer Care: Genomic Profiling, AI, and Next-Generation Drug Delivery Systems2026 · 2 citations
  3. 3The tumor microenvironment and its immunosuppressive characteristics-IFN-γ immunotherapy approaches2026
  4. 4Neoantigen in cancer immunotherapy: mechanism, therapeutic strategies and future perspectives2026
  5. 5Single-cell multi-omics in cancer immunotherapy: from tumor heterogeneity to personalized precision treatment2025